According to Zacks, “CRH Medical Corporation offers products and services to physicians for the treatment of gastrointestinal diseases primarily in the United States. The company provides the CRH O’Regan System, a single use, disposable and hemorrhoid banding technology for treating hemorrhoid grades I – IV. It distributes the CRH O’Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to physicians. The company utilizes Web-based platform to connect doctors with patients as well as educating its install base of physicians. It also offers anesthesia services. CRH Medical Corporation is headquartered in Vancouver, Canada. “
Separately, Bloom Burton upgraded CRH Medical from an “accumulate” rating to a “buy” rating in a report on Thursday, August 1st. One analyst has rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $3.25.
CRH Medical stock traded up $0.07 during midday trading on Tuesday, reaching $3.29. 37,100 shares of the company’s stock were exchanged, compared to its average volume of 66,295. CRH Medical has a 52 week low of $2.51 and a 52 week high of $4.50.
CRH Medical (NYSEAMERICAN:CRHM) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.01. The business had revenue of $30.48 million for the quarter, compared to the consensus estimate of $29.50 million.
Institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC boosted its holdings in shares of CRH Medical by 3.5% during the second quarter. Renaissance Technologies LLC now owns 669,700 shares of the company’s stock worth $2,029,000 after acquiring an additional 22,500 shares during the period. Wedge Capital Management L L P NC boosted its holdings in shares of CRH Medical by 25.7% during the first quarter. Wedge Capital Management L L P NC now owns 118,903 shares of the company’s stock worth $316,000 after acquiring an additional 24,347 shares during the period. Two Sigma Advisers LP boosted its holdings in shares of CRH Medical by 12.6% during the fourth quarter. Two Sigma Advisers LP now owns 220,300 shares of the company’s stock worth $675,000 after acquiring an additional 24,700 shares during the period. Pacific Ridge Capital Partners LLC boosted its holdings in shares of CRH Medical by 1.7% during the second quarter. Pacific Ridge Capital Partners LLC now owns 2,111,335 shares of the company’s stock worth $6,397,000 after acquiring an additional 34,687 shares during the period. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp bought a new stake in shares of CRH Medical during the first quarter worth approximately $236,000.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.
Further Reading: What is the CBOE Russell 2000® Volatility Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.